74 related articles for article (PubMed ID: 80152)
1. [Search for new antitumor antibiotics in the bleomycin group].
Gauze GF; Maksimova TS; Ol'khovatova OL
Antibiotiki; 1978 Aug; 23(8):675-6. PubMed ID: 80152
[TBL] [Abstract][Full Text] [Related]
2. Screening for new antitumor antibiotics of the bleomycin group.
Gause GF; Maximova TS; Olchovatova OL
Cancer Treat Rep; 1978 Aug; 62(8):1227-8. PubMed ID: 80273
[No Abstract] [Full Text] [Related]
3. In vitro evaluation of the new anticancer agents KT6149, MX-2, SM5887, menogaril, and liblomycin using cisplatin- or adriamycin-resistant human cancer cell lines.
Ohe Y; Nakagawa K; Fujiwara Y; Sasaki Y; Minato K; Bungo M; Niimi S; Horichi N; Fukuda M; Saijo N
Cancer Res; 1989 Aug; 49(15):4098-102. PubMed ID: 2472873
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the sequences at specific sites on DNA cleaved by the antitumor antibiotics talisomycin and bleomycin.
Mirabelli CK; Beattie WG; Huang CH; Prestayko AW; Crooke ST
Cancer Res; 1982 Apr; 42(4):1399-404. PubMed ID: 6174223
[TBL] [Abstract][Full Text] [Related]
5. [Effect of microbial and tumor cell adaptation to rubomycin on their uptake of rubomycin and carminomycin].
Ostanina LN; Averbukh LA; Karpov VL; Dudnik IuV; Liashenko VA
Antibiotiki; 1978 Sep; 23(9):837-40. PubMed ID: 697342
[TBL] [Abstract][Full Text] [Related]
6. [Studies on the mechanism of drug resistance in tumor cells and a new antitumor antibiotic].
Tanaka N
Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2666-73. PubMed ID: 6210060
[TBL] [Abstract][Full Text] [Related]
7. The ShBle resistance determinant from Streptoalloteichus hindustanus is expressed in Haloferax volcanii and confers resistance to bleomycin.
Nuttall SD; Deutschel SE; Irving RA; Serrano-Gomicia JA; Dyall-Smith ML
Biochem J; 2000 Mar; 346 Pt 2(Pt 2):251-4. PubMed ID: 10677341
[TBL] [Abstract][Full Text] [Related]
8. [Mutagenesis in Streptomycete cultures exposed to bleomycin].
Lapchinskaia OA; Siniagina OP; Filicheva VA; L'vova NA
Antibiotiki; 1982 Feb; 27(2):147-50. PubMed ID: 6175272
[TBL] [Abstract][Full Text] [Related]
9. [Role of antibiotics in the ecology of actinomycetes].
Gauze GF; Maksimova TS; Ol'khovatova OL
Antibiotiki; 1979 Feb; 24(2):83-6. PubMed ID: 434803
[TBL] [Abstract][Full Text] [Related]
10. A novel transformation system using a bleomycin resistance marker with chemosensitizers for Aspergillus oryzae.
Suzuki S; Tada S; Fukuoka M; Taketani H; Tsukakoshi Y; Matsushita M; Oda K; Kusumoto K; Kashiwagi Y; Sugiyama M
Biochem Biophys Res Commun; 2009 May; 383(1):42-7. PubMed ID: 19324021
[TBL] [Abstract][Full Text] [Related]
11. Effects of DNA superhelical changes induced by ethidium bromide on the DNA-degrading activity of two antitumor antibiotics, bleomycin and phleomycin.
Huang CH; Mirabelli CK; Mong S; Crooke ST
Cancer Res; 1983 Jun; 43(6):2849-56. PubMed ID: 6189587
[TBL] [Abstract][Full Text] [Related]
12. [Secondary microbial metabolites with potentials for antineoplastic actions: antineoplastic antibiotics and immunopotentiators].
Umezawa H
Gan To Kagaku Ryoho; 1983 Apr; 10(4 Pt 2):1071-86. PubMed ID: 6191672
[TBL] [Abstract][Full Text] [Related]
13. [Validity of chromosome analysis and bleomycin sensitivity assay in the prevention of head and neck cancer in Hungary].
Székely G; Remenár E; Kásler M; Bodrog A; Gundy S
Orv Hetil; 2001 Mar; 142(12):611-6. PubMed ID: 11324219
[TBL] [Abstract][Full Text] [Related]
14. [Systematic position and variability of the producent of antitumor antibiotic bruneomycin].
Kudrina ES; Ol'khovatova OL; Murav'eva LI; Gauze GF
Antibiotiki; 1966 May; 11(5):400-5. PubMed ID: 4967040
[No Abstract] [Full Text] [Related]
15. Structure and function of "metalloantibiotics".
Ming LJ
Med Res Rev; 2003 Nov; 23(6):697-762. PubMed ID: 12939790
[TBL] [Abstract][Full Text] [Related]
16. Recent studies on antibiotics and small molecular immunomodulators with potential usefulness in treating lung cancer: Part I - Antitumor antibiotics and their derivatives.
Umezawa H
Int J Clin Pharmacol Ther Toxicol; 1982 Jan; 20(1):12-8. PubMed ID: 6173340
[TBL] [Abstract][Full Text] [Related]
17. Effect of structural modifications of anthracyclines on the ability to overcome drug resistance of cancer cells.
Wasowska M; Wietrzyk J; Opolski A; Oszczapowicz J; Oszczapowicz I
Anticancer Res; 2006; 26(3A):2009-12. PubMed ID: 16827137
[TBL] [Abstract][Full Text] [Related]
18. [Optimal administration schedules of antineoplastic antibiotics based on their pharmacokinetics, with special reference to bleomycins and anthracyclines].
Ota K; Goto T; Fukushima M; Ariyoshi Y
Gan To Kagaku Ryoho; 1982 Aug; 9(8):1352-61. PubMed ID: 6191712
[TBL] [Abstract][Full Text] [Related]
19. Bleomycin.
Lazo JS; Sebti SM
Cancer Chemother Biol Response Modif; 1997; 17():40-5. PubMed ID: 9551207
[No Abstract] [Full Text] [Related]
20. Additive effects of bleomycin and neocarzinostatin on degradation of DNA, inhibition of DNA polymerase beta, and cell growth.
Müller WE; Maidhof A; Arendes J; Geurtsen W; Zahn RK; Schmidseder R
Cancer Res; 1979 Sep; 39(9):3768-73. PubMed ID: 89904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
